Global Major Depressive Disorder Market Outlook 2018-2025 : Industry Trends, Analysis, Opportunities, Sales, Segmentation, Revenue and Forecast


 Published Date : Oct-2018  |   Publisher : Reports Buzz  |   Format : PDF

 Buy Now

This report focuses on the global Major Depressive Disorder status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Major Depressive Disorder development in United States, Europe and China.

Major depressive disorder, also known as major depression and clinical depression, is a mental disorder characterized by loss of interest and pleasure in enjoyable environment. People are affected in different ways by major depression. Some people have trouble sleeping, feel agitated and irritable, and have sudden weight loss. Moreover, they can have other mental and physical symptoms such as fatigue, memory loss, feeling of hopelessness, body aches, headaches, and thoughts of suicide.
In terms of geography, North America dominates the global major depressive disorder market due to increased awareness about various depression conditions in the region. The U.S. represents the largest market for major depressive disorder in North America, followed by Canada. In Europe, Germany, France, the U.K., Italy, and Spain account for a major share of the major depressive disorder market. This market in Asia is expected to expand at a significant rate over the next five years. This is due to various companies setting up manufacturing facilities in the region. Moreover, increasing awareness about various depression episodes and rise in geriatric population are also driving the growth of the market in the region. India, China, and Japan are expected to be the fastest growing major depressive disorder markets in Asia.
In 2017, the global Major Depressive Disorder market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study
    Pfizer
    Eli Lilly
    H. Lundbeck
    Otsuka Pharmaceutical
    AstraZeneca
    Alkermes
    Takeda Pharmaceutical
    Naurex
    Euthymics Bioscience
    E-therapeutics

Market segment by Type, the product can be split into
    Drugs Therapy
    Biological Therapy
    Meditation
    Physiotherapy
    Other

Market segment by Application, split into
    Under 25 Years Old
    25-45 Years Old
    Above 45 Years Old

Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global Major Depressive Disorder status, future forecast, growth opportunity, key market and key players.
    To present the Major Depressive Disorder development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Major Depressive Disorder are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
        1.4.1 Global Major Depressive Disorder Market Size Growth Rate by Type (2013-2025)
        1.4.2 Drugs Therapy
        1.4.3 Biological Therapy
        1.4.4 Meditation
        1.4.5 Physiotherapy
        1.4.6 Other
    1.5 Market by Application
        1.5.1 Global Major Depressive Disorder Market Share by Application (2013-2025)
        1.5.2 Under 25 Years Old
        1.5.3 25-45 Years Old
        1.5.4 Above 45 Years Old
    1.6 Study Objectives
    1.7 Years Considered

2 Global Growth Trends
    2.1 Major Depressive Disorder Market Size
    2.2 Major Depressive Disorder Growth Trends by Regions
        2.2.1 Major Depressive Disorder Market Size by Regions (2013-2025)
        2.2.2 Major Depressive Disorder Market Share by Regions (2013-2018)
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Drivers
        2.3.3 Market Opportunities

3 Market Share by Key Players
    3.1 Major Depressive Disorder Market Size by Manufacturers
        3.1.1 Global Major Depressive Disorder Revenue by Manufacturers (2013-2018)
        3.1.2 Global Major Depressive Disorder Revenue Market Share by Manufacturers (2013-2018)
        3.1.3 Global Major Depressive Disorder Market Concentration Ratio (CR5 and HHI)
    3.2 Major Depressive Disorder Key Players Head office and Area Served
    3.3 Key Players Major Depressive Disorder Product/Solution/Service
    3.4 Date of Enter into Major Depressive Disorder Market
    3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
    4.1 Global Major Depressive Disorder Market Size by Type (2013-2018)
    4.2 Global Major Depressive Disorder Market Size by Application (2013-2018)

5 United States
    5.1 United States Major Depressive Disorder Market Size (2013-2018)
    5.2 Major Depressive Disorder Key Players in United States
    5.3 United States Major Depressive Disorder Market Size by Type
    5.4 United States Major Depressive Disorder Market Size by Application

6 Europe
    6.1 Europe Major Depressive Disorder Market Size (2013-2018)
    6.2 Major Depressive Disorder Key Players in Europe
    6.3 Europe Major Depressive Disorder Market Size by Type
    6.4 Europe Major Depressive Disorder Market Size by Application

7 China
    7.1 China Major Depressive Disorder Market Size (2013-2018)
    7.2 Major Depressive Disorder Key Players in China
    7.3 China Major Depressive Disorder Market Size by Type
    7.4 China Major Depressive Disorder Market Size by Application

8 Japan
    8.1 Japan Major Depressive Disorder Market Size (2013-2018)
    8.2 Major Depressive Disorder Key Players in Japan
    8.3 Japan Major Depressive Disorder Market Size by Type
    8.4 Japan Major Depressive Disorder Market Size by Application

9 Southeast Asia
    9.1 Southeast Asia Major Depressive Disorder Market Size (2013-2018)
    9.2 Major Depressive Disorder Key Players in Southeast Asia
    9.3 Southeast Asia Major Depressive Disorder Market Size by Type
    9.4 Southeast Asia Major Depressive Disorder Market Size by Application

10 India
    10.1 India Major Depressive Disorder Market Size (2013-2018)
    10.2 Major Depressive Disorder Key Players in India
    10.3 India Major Depressive Disorder Market Size by Type
    10.4 India Major Depressive Disorder Market Size by Application

11 Central & South America
    11.1 Central & South America Major Depressive Disorder Market Size (2013-2018)
    11.2 Major Depressive Disorder Key Players in Central & South America
    11.3 Central & South America Major Depressive Disorder Market Size by Type
    11.4 Central & South America Major Depressive Disorder Market Size by Application

12 International Players Profiles
    12.1 Pfizer
        12.1.1 Pfizer Company Details
        12.1.2 Company Description and Business Overview
        12.1.3 Major Depressive Disorder Introduction
        12.1.4 Pfizer Revenue in Major Depressive Disorder Business (2013-2018)
        12.1.5 Pfizer Recent Development
    12.2 Eli Lilly
        12.2.1 Eli Lilly Company Details
        12.2.2 Company Description and Business Overview
        12.2.3 Major Depressive Disorder Introduction
        12.2.4 Eli Lilly Revenue in Major Depressive Disorder Business (2013-2018)
        12.2.5 Eli Lilly Recent Development
    12.3 H. Lundbeck
        12.3.1 H. Lundbeck Company Details
        12.3.2 Company Description and Business Overview
        12.3.3 Major Depressive Disorder Introduction
        12.3.4 H. Lundbeck Revenue in Major Depressive Disorder Business (2013-2018)
        12.3.5 H. Lundbeck Recent Development
    12.4 Otsuka Pharmaceutical
        12.4.1 Otsuka Pharmaceutical Company Details
        12.4.2 Company Description and Business Overview
        12.4.3 Major Depressive Disorder Introduction
        12.4.4 Otsuka Pharmaceutical Revenue in Major Depressive Disorder Business (2013-2018)
        12.4.5 Otsuka Pharmaceutical Recent Development
    12.5 AstraZeneca
        12.5.1 AstraZeneca Company Details
        12.5.2 Company Description and Business Overview
        12.5.3 Major Depressive Disorder Introduction
        12.5.4 AstraZeneca Revenue in Major Depressive Disorder Business (2013-2018)
        12.5.5 AstraZeneca Recent Development
    12.6 Alkermes
        12.6.1 Alkermes Company Details
        12.6.2 Company Description and Business Overview
        12.6.3 Major Depressive Disorder Introduction
        12.6.4 Alkermes Revenue in Major Depressive Disorder Business (2013-2018)
        12.6.5 Alkermes Recent Development
    12.7 Takeda Pharmaceutical
        12.7.1 Takeda Pharmaceutical Company Details
        12.7.2 Company Description and Business Overview
        12.7.3 Major Depressive Disorder Introduction
        12.7.4 Takeda Pharmaceutical Revenue in Major Depressive Disorder Business (2013-2018)
        12.7.5 Takeda Pharmaceutical Recent Development
    12.8 Naurex
        12.8.1 Naurex Company Details
        12.8.2 Company Description and Business Overview
        12.8.3 Major Depressive Disorder Introduction
        12.8.4 Naurex Revenue in Major Depressive Disorder Business (2013-2018)
        12.8.5 Naurex Recent Development
    12.9 Euthymics Bioscience
        12.9.1 Euthymics Bioscience Company Details
        12.9.2 Company Description and Business Overview
        12.9.3 Major Depressive Disorder Introduction
        12.9.4 Euthymics Bioscience Revenue in Major Depressive Disorder Business (2013-2018)
        12.9.5 Euthymics Bioscience Recent Development
    12.10 E-therapeutics
        12.10.1 E-therapeutics Company Details
        12.10.2 Company Description and Business Overview
        12.10.3 Major Depressive Disorder Introduction
        12.10.4 E-therapeutics Revenue in Major Depressive Disorder Business (2013-2018)
        12.10.5 E-therapeutics Recent Development

13 Market Forecast 2018-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2018-2025)
    13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            12.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details



List of Tables and Figures

    Table Major Depressive Disorder Key Market Segments
    Table Key Players Major Depressive Disorder Covered
    Table Global Major Depressive Disorder Market Size Growth Rate by Type 2013-2025 (Million US$)
    Figure Global Major Depressive Disorder Market Size Market Share by Type 2013-2025
    Figure Drugs Therapy Figures
    Table Key Players of Drugs Therapy
    Figure Biological Therapy Figures
    Table Key Players of Biological Therapy
    Figure Meditation Figures
    Table Key Players of Meditation
    Figure Physiotherapy Figures
    Table Key Players of Physiotherapy
    Figure Other Figures
    Table Key Players of Other
    Table Global Major Depressive Disorder Market Size Growth by Application 2013-2025 (Million US$)
    Figure Under 25 Years Old Case Studies
    Figure 25-45 Years Old Case Studies
    Figure Above 45 Years Old Case Studies
    Figure Major Depressive Disorder Report Years Considered
    Table Global Major Depressive Disorder Market Size 2013-2025 (Million US$)
    Figure Global Major Depressive Disorder Market Size and Growth Rate 2013-2025 (Million US$)
    Table Global Major Depressive Disorder Market Size by Regions 2013-2025 (Million US$)
    Table Global Major Depressive Disorder Market Size by Regions 2013-2018 (Million US$)
    Table Global Major Depressive Disorder Market Share by Regions 2013-2018
    Figure Global Major Depressive Disorder Market Share by Regions 2013-2018
    Figure Global Major Depressive Disorder Market Share by Regions 2018
    Table Market Top Trends
    Table Global Major Depressive Disorder Revenue by Manufacturers (2013-2018) (Million US$)
    Table Global Major Depressive Disorder Market Share by Manufacturers (2013-2018)
    Figure Global Major Depressive Disorder Market Share by Manufacturers in 2018
    Table Global Major Depressive Disorder Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Players Head office and Area Served
    Table Key Players Major Depressive Disorder Product/Solution/Service
    Table Date of Enter into Major Depressive Disorder Market
    Table Mergers & Acquisitions, Expansion Plans
    Table Global Major Depressive Disorder Market Size by Type (2013-2018) (Million US$)
    Table Global Major Depressive Disorder Market Size Share by Type (2013-2018)
    Figure Global Major Depressive Disorder Market Size Market Share by Type (2013-2018)
    Table Global Major Depressive Disorder Market Size by Application (2013-2018) (Million US$)
    Table Global Major Depressive Disorder Market Size Share by Application (2013-2018)
    Figure Global Major Depressive Disorder Market Size Market Share by Application (2013-2018)
    Figure Global Major Depressive Disorder Revenue Market Share by Application in 2017
    Figure United States Major Depressive Disorder Market Size 2013-2018 (Million US$)
    Table United States Key Players Major Depressive Disorder Revenue (2017-2018) (Million US$)
    Table United States Key Players Major Depressive Disorder Market Share (2017-2018)
    Table United States Major Depressive Disorder Market Size by Type (2013-2018) (Million US$)
    Table United States Major Depressive Disorder Market Share by Type (2013-2018)
    Table United States Major Depressive Disorder Market Size by Application (2013-2018) (Million US$)
    Table United States Major Depressive Disorder Market Share by Application (2013-2018)
    Figure Europe Major Depressive Disorder Market Size 2013-2018 (Million US$)
    Table Europe Key Players Major Depressive Disorder Revenue (2017-2018) (Million US$)
    Table Europe Key Players Major Depressive Disorder Market Share (2017-2018)
    Table Europe Major Depressive Disorder Market Size by Type (2013-2018) (Million US$)
    Table Europe Major Depressive Disorder Market Share by Type (2013-2018)
    Table Europe Major Depressive Disorder Market Size by Application (2013-2018) (Million US$)
    Table Europe Major Depressive Disorder Market Share by Application (2013-2018)
    Figure China Major Depressive Disorder Market Size 2013-2018 (Million US$)
    Table China Key Players Major Depressive Disorder Revenue (2017-2018) (Million US$)
    Table China Key Players Major Depressive Disorder Market Share (2017-2018)
    Table China Major Depressive Disorder Market Size by Type (2013-2018) (Million US$)
    Table China Major Depressive Disorder Market Share by Type (2013-2018)
    Table China Major Depressive Disorder Market Size by Application (2013-2018) (Million US$)
    Table China Major Depressive Disorder Market Share by Application (2013-2018)
    Figure Japan Major Depressive Disorder Market Size 2013-2018 (Million US$)
    Table Japan Key Players Major Depressive Disorder Revenue (2017-2018) (Million US$)
    Table Japan Key Players Major Depressive Disorder Market Share (2017-2018)
    Table Japan Major Depressive Disorder Market Size by Type (2013-2018) (Million US$)
    Table Japan Major Depressive Disorder Market Share by Type (2013-2018)
    Table Japan Major Depressive Disorder Market Size by Application (2013-2018) (Million US$)
    Table Japan Major Depressive Disorder Market Share by Application (2013-2018)
    Figure Southeast Asia Major Depressive Disorder Market Size 2013-2018 (Million US$)
    Table Southeast Asia Key Players Major Depressive Disorder Revenue (2017-2018) (Million US$)
    Table Southeast Asia Key Players Major Depressive Disorder Market Share (2017-2018)
    Table Southeast Asia Major Depressive Disorder Market Size by Type (2013-2018) (Million US$)
    Table Southeast Asia Major Depressive Disorder Market Share by Type (2013-2018)
    Table Southeast Asia Major Depressive Disorder Market Size by Application (2013-2018) (Million US$)
    Table Southeast Asia Major Depressive Disorder Market Share by Application (2013-2018)
    Figure India Major Depressive Disorder Market Size 2013-2018 (Million US$)
    Table India Key Players Major Depressive Disorder Revenue (2017-2018) (Million US$)
    Table India Key Players Major Depressive Disorder Market Share (2017-2018)
    Table India Major Depressive Disorder Market Size by Type (2013-2018) (Million US$)
    Table India Major Depressive Disorder Market Share by Type (2013-2018)
    Table India Major Depressive Disorder Market Size by Application (2013-2018) (Million US$)
    Table India Major Depressive Disorder Market Share by Application (2013-2018)
    Figure Central & South America Major Depressive Disorder Market Size 2013-2018 (Million US$)
    Table Central & South America Key Players Major Depressive Disorder Revenue (2017-2018) (Million US$)
    Table Central & South America Key Players Major Depressive Disorder Market Share (2017-2018)
    Table Central & South America Major Depressive Disorder Market Size by Type (2013-2018) (Million US$)
    Table Central & South America Major Depressive Disorder Market Share by Type (2013-2018)
    Table Central & South America Major Depressive Disorder Market Size by Application (2013-2018) (Million US$)
    Table Central & South America Major Depressive Disorder Market Share by Application (2013-2018)
    Table Pfizer Company Details
    Table Pfizer Revenue in Major Depressive Disorder Business (2013-2018) (Million US$)
    Figure Pfizer Revenue Growth Rate in Major Depressive Disorder Business (2013-2018)
    Table Pfizer Recent Development
    Table Eli Lilly Company Details
    Table Eli Lilly Revenue in Major Depressive Disorder Business (2013-2018)(Million US$)
    Figure Eli Lilly Revenue Growth Rate in Major Depressive Disorder Business (2013-2018)
    Table Eli Lilly Recent Development
    Table H. Lundbeck Company Details
    Table H. Lundbeck Revenue in Major Depressive Disorder Business (2013-2018)(Million US$)
    Figure H. Lundbeck Revenue Growth Rate in Major Depressive Disorder Business (2013-2018)
    Table H. Lundbeck Recent Development
    Table Otsuka Pharmaceutical Company Details
    Table Otsuka Pharmaceutical Revenue in Major Depressive Disorder Business (2013-2018)(Million US$)
    Figure Otsuka Pharmaceutical Revenue Growth Rate in Major Depressive Disorder Business (2013-2018)
    Table Otsuka Pharmaceutical Recent Development
    Table AstraZeneca Company Details
    Table AstraZeneca Revenue in Major Depressive Disorder Business (2013-2018)(Million US$)
    Figure AstraZeneca Revenue Growth Rate in Major Depressive Disorder Business (2013-2018)
    Table AstraZeneca Recent Development
    Table Alkermes Company Details
    Table Alkermes Revenue in Major Depressive Disorder Business (2013-2018)(Million US$)
    Figure Alkermes Revenue Growth Rate in Major Depressive Disorder Business (2013-2018)
    Table Alkermes Recent Development
    Table Takeda Pharmaceutical Company Details
    Table Takeda Pharmaceutical Revenue in Major Depressive Disorder Business (2013-2018)(Million US$)
    Figure Takeda Pharmaceutical Revenue Growth Rate in Major Depressive Disorder Business (2013-2018)
    Table Takeda Pharmaceutical Recent Development
    Table Naurex Company Details
    Table Naurex Revenue in Major Depressive Disorder Business (2013-2018)(Million US$)
    Figure Naurex Revenue Growth Rate in Major Depressive Disorder Business (2013-2018)
    Table Naurex Recent Development
    Table Euthymics Bioscience Company Details
    Table Euthymics Bioscience Revenue in Major Depressive Disorder Business (2013-2018)(Million US$)
    Figure Euthymics Bioscience Revenue Growth Rate in Major Depressive Disorder Business (2013-2018)
    Table Euthymics Bioscience Recent Development
    Table E-therapeutics Company Details
    Table E-therapeutics Revenue in Major Depressive Disorder Business (2013-2018)(Million US$)
    Figure E-therapeutics Revenue Growth Rate in Major Depressive Disorder Business (2013-2018)
    Table E-therapeutics Recent Development
    Table Global Major Depressive Disorder Market Size by Regions (Million US$) 2018-2025
    Figure Global Major Depressive Disorder Market Size Share by Regions (2018-2025)
    Figure Global Major Depressive Disorder Market Size Share by Regions in 2025
    Figure United States Major Depressive Disorder Market Size Forecast (2018-2025)(Million USD)
    Figure Europe Major Depressive Disorder Market Size Forecast (2018-2025)(Million USD)
    Figure China Major Depressive Disorder Market Size Forecast (2018-2025)(Million USD)
    Figure Japan Major Depressive Disorder Market Size Forecast (2018-2025)(Million USD)
    Figure Southeast Asia Major Depressive Disorder Market Size Forecast (2018-2025)(Million USD)
    Figure India Major Depressive Disorder Market Size Forecast (2018-2025)(Million USD)
    Figure Central & South America Major Depressive Disorder Market Size Forecast (2018-2025)(Million USD)
    Table Global Major Depressive Disorder Market Size by Product (2018-2025) (Million US$)
    Figure Global Major Depressive Disorder Market Size by Product (2018-2025)
    Figure Global Major Depressive Disorder Market Size by Product in 2025
    Table Global Major Depressive Disorder Market Size by Application (2018-2025) (Million US$)
    Figure Global Major Depressive Disorder Market Size by Application (2018-2025)
    Figure Global Major Depressive Disorder Market Size by Application in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

LATEST NEWS

Drop In Material Wastage To Spur The Automotive 3D Printing Market
 17-Sep-2020  /   Automobile

Three-dimensional printing or additive printing technology enables the manufacturers to make models using a range of printing substances. Although 3D printing technology is in its budding phase in the automotive segment, the technology is anticipated to get a grip in the near future. The materials utilized for automotive 3D printing consist of a variety of types of ceramics, metals, polymers, a ...

Manufacturing Sector Impacted, Overall Industrial Production Slowed By 2.2%
 13-Jul-2020  /   Machinery and Tools

In the manufacturing and mining sector, due to the decline in production of consumer products, the growth in industrial production declined to 2.2% in October. This is the minimum level of industrial production increase in last three months.

According to the figures released by the Central Statistics Office today, industrial production growth was 4.2% in October last year. In Septembe ...

Supply Chain And Logistics Sector Will Be The Key Driver For Job Market
 13-Jul-2020  /   Others

There has been a drastic fluctuation in the employment ratio. A specific drop in the recruitment sector has been witnessed. But the picture in the logistics and supply chain seems to be different, as the sector is expected to create a considerable number of jobs in the coming period. The projection is based on the two big government moves buoyed by the companies and the expenditure of spending ...






Our Clients

We are here to help you Get in touch quickly.

48 hours! That’s all you need to get a detailed market research of any specific industry.